AC Immune S.A. logo

AC Immune S.A.

ACIU | NASDAQ
Chart Builder DCF Calculator
$2.73
+$0.08 (+2.82%)
Sep 22, 2026, 2:15 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-67.28M -50.92M -54.23M -70.75M -73M -61.92M
Depreciation & Amortization
2.39M 2.16M 2.22M 2.36M 2.41M 1.97M
Stock-Based Compensation
n/a 5.47M 4.37M 3.33M 4.13M 4.09M
Other Working Capital
-6.78M 93.96M -360K -9.04M 6.94M -4.04M
Other Non-Cash Items
5.21M 1.61M 2.41M -72K -6.2M 922K
Deferred Income Tax
n/a n/a n/a n/a 130K n/a
Change in Working Capital
-6.47M 107.51M -15.16M -8.43M 6.84M -4.57M
Operating Cash Flow
-66.15M 65.84M -60.41M -73.57M -65.69M -59.52M
Capital Expenditures
-859.54K -576K -801K -1.24M -2.64M -1.71M
Cash Acquisitions
14.33K n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
61.69M n/a n/a n/a n/a n/a
Other Investing Acitivies
-162.36K -104.71M 66.45M 25M -51.03M 30.04M
Investing Cash Flow
60.69M -105.29M 65.65M 23.76M -53.66M 28.33M
Debt Repayment
-1.03M -683K -548K -569K 22.95M -946K
Common Stock Repurchased
n/a n/a n/a -8K n/a -100K
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
46.13K -548K n/a -776K -6K 143K
Financial Cash Flow
-974.14K -1.12M 43.25M -1.35M 40.75M -803K
Net Cash Flow
-4.92M -42.22M 46.91M -50.63M -78.68M -32.69M
Free Cash Flow
-67.01M 65.27M -61.21M -74.81M -68.32M -61.22M
Adj. Free Cash Flow
-67.01M 59.8M -65.57M -78.14M -72.45M -65.31M
Maintenance CapEx
-859.54K n/a n/a -482.34K -2.64M -1.71M
Growth CapEx
n/a -576K -801K -756.66K n/a n/a
Owner Earnings
-67.01M 65.84M -60.41M -74.05M -68.32M -61.22M

© 2026 bestshares.com. All rights reserved.